Taiwan FDA registration 5d88f2914b8b0484d3e46296514403e2

"Bidi" CD16 reagent

TW: "必帝" CD16 試劑

Taiwan·Risk Class 2·BD BIOSCIENCES IMMUNOCYTOMETRY SYSTEMS, A UNIT OF BECTON, DICKINSON AND COMPANY·Registered Mar 06, 2006 – Mar 06, 2011Cancelled

Registration details

Analysis ID: 5d88f2914b8b0484d3e46296514403e2
Customs Code: DHA00601608800

Company information

Manufacturer: BD BIOSCIENCES IMMUNOCYTOMETRY SYSTEMS, A UNIT OF BECTON, DICKINSON AND COMPANY
Manufacturer Country: United States
Authorized Representative: Taiwan Branch of American Business Bidi Co., Ltd

Product details

Intended Use: It is used to measure the presence or absence of human leukocyte antigen CD16.
Product Type (Level 1): B Hematology, pathology, and genetics
Product Type (Level 2): B.5220 Automatic Differentiation Cell Counter
Import Information: import

Dates and status

Registration Date: Mar 06, 2006
Expiry Date: Mar 06, 2011
Cancellation Date: Oct 26, 2012

Cancellation information

Status: Logged out
Reason: 許可證已逾有效期

About this record

Access comprehensive regulatory information for "Bidi" CD16 reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5d88f2914b8b0484d3e46296514403e2 and manufactured by BD BIOSCIENCES IMMUNOCYTOMETRY SYSTEMS, A UNIT OF BECTON, DICKINSON AND COMPANY. The authorized representative in Taiwan is Taiwan Branch of American Business Bidi Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.